Skip to main content
. 2022 Aug 18;13:943408. doi: 10.3389/fendo.2022.943408

Table 1.

Overview of research on gut microbiota and thyroid diseases.

Diseases Country Year Sample size Methods Ref
TC China 2018 30 TC, 35 HC 16S rRNA gene sequencing, metabolomics (16)
TC & TN China 2018 20 TC, 18 TN, 36 HC 16S rRNA gene sequencing (17)
TC China 2022 90 TC, 90 HC 16S rRNA gene sequencing (18)
AITD (HT) China 2017 29 HT, 12 HC DGGE, RT-PCR, Pyrosequencing (19)
AITD (HT) China 2018 28 HT, 16 HC 16S rRNA gene sequencing (20)
AITD (HT) China 2020 63 HT, 34 HC 16S rRNA gene sequencing (21)
AITD (HT and GD) Spain 2020 9 HT, 9 GD, 11 HC 16S rRNA gene sequencing (22)
AITD (HT and GD) Egypt 2021 7 HT, 13 GD, 30 HC SYBR green RT-PCR (23)
AITD (hyperthyroidism) China 2014 14 hyperthyroidism, 7 HC DGGE, RT-PCR, sequencing (24)
AITD (GD) China and Pakistan 2018 27 GD, 11 HC DGGE, RT-PCR, 16S rRNA gene sequencing (25)
AITD (GD) China 2021 45 GD, 59 HC 16S rRNA gene sequencing (26)
AITD (GD) China 2021 15 GD, 14 HC 16S rRNA gene sequencing (27)
hypothyroidism China 2020 52 hypothyroidism, 40 HC 16S rRNA gene sequencing (28)
subclinical hypothyroidism China 2020 117 patients 16S rRNA gene sequencing (29)

TC, thyroid cancer; HC, healthy controls; TN, thyroid nodule; AITD, autoimmunity thyroid diseases; HT, Hashimoto’s thyroiditis; GD, Graves’ Disease; RT-PCR, real time-polymerase chain reaction; DGGE, denaturing gradient gel electrophoresis.